Folate 800 µg x 60 tablets
- FOLIAN for pregnant women 800 by ALINESS is a rich source of highly bioavailable folate in the patented form of Quaterfolic®.
Folate 800 µg x 60 tablets
Ingredients: bulking agent: microcrystalline cellulose, glucosamine salt of (6S)-5-methyltetrahydrofolic acid Quatrefolic®.
Recommended daily dose necessary to obtain the beneficial effect of the product:
1 tablet daily, during a meal. Do not exceed recommended servings for consumption during the day.
The product is dedicated to pregnant women. Use in pregnant women after consulting a doctor.
The product cannot be used as a substitute for a varied diet.
It is recommended to follow a varied diet and a healthy lifestyle.
Package contents: 60 VEGE tablets
Storage conditions: Store at room temperature out of the reach of small children. Protect from moisture.
ACTION OF FOLATES:
- contribute to the growth of maternal tissues during pregnancy
- reduce the risk of developing neural tube defects in the developing fetus
- help in proper blood production
- help maintain proper homocysteine metabolism
- help maintain proper psychological functions
- contribute to reducing the feeling of fatigue and weariness
- help in the proper functioning of the immune system
- they take part in the process of cell division
- help in the proper synthesis of amino acids
The term "Folic acid" includes all forms of folates. In English, "folate" sounds similar to "leaves", and this is not a coincidence. The words share a common root (the Latin word folium, meaning "leaf"), which is a reminder that green plant foods can be one of the richest sources of folate.
Folates are susceptible to oxidation, rapidly lose their activity in food and are largely (up to 90%) destroyed by cooking.
Synthetic folic acid
Folic acid obtained from food must be metabolized to 5-methyltetrahydrofolate (5-MTHF) to achieve full metabolic effectiveness.
Most of our folate intake comes from synthetic versions of folic acid in supplements and added to foods. Today we know that folic acid undergoes complex metabolism and that there are differences among populations in the ability to effectively metabolize folic acid into its bioactive form (1,2).
Folate in food is hydrolyzed to monoglutamate in the intestine before being absorbed by active transport through the intestinal mucosa. Therefore, before entering the bloodstream, the monoglutamate form is reduced to tetrahydrofolate (THF) and converted to methyl forms.
Folic acid, on the other hand, is first reduced to dihydrofolate by the enzyme dehydrofolate reductase (DHFR) and then to tetrahydrofolate. In humans, the intestine appears to have a very high capacity to convert reduced folate from food into 5-MTHF, but a limited capacity to reduce folate. In fact, it reaches the liver in an unmetabolized form.
